Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07202845) titled 'Early Prediction of Neoadjuvant Chemotherapy Response in Bladder Cancer Using Quantitative Multiparametric MRI' on Sept. 24.

Study Type: Observational

Primary Sponsor: Assiut University

Condition: MIBC mpMRI NAC

Intervention: Diagnostic Test: Multiparametric Magnetic Resonance Imaging (mpMRI)

Recruitment Status: Recruiting

Date of First Enrollment: August 29, 2025

Target Sample Size: 39

Countries of Recruitment: Egypt

To know more, visit https://clinicaltrials.gov/study/NCT07202845

Published by HT Digital Content Services with permission from Health Daily Digest....